These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 198601

  • 1. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P, Schwandt P.
    Klin Wochenschr; 1977 Aug 15; 55(16):791-4. PubMed ID: 198601
    [Abstract] [Full Text] [Related]

  • 2. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Aug 15; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 3. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
    Carlson LA, Olsson G, Ballantyne D.
    Atherosclerosis; 1977 Apr 15; 26(4):603-9. PubMed ID: 193526
    [Abstract] [Full Text] [Related]

  • 4. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE, Lees RS.
    J Clin Invest; 1972 May 15; 51(5):1051-7. PubMed ID: 4341500
    [Abstract] [Full Text] [Related]

  • 5. Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia.
    Ballantyne D, Ballantyne FC, Stromberg P, Third JL, Bedford DK.
    Clin Chim Acta; 1978 Feb 01; 83(1-2):117-22. PubMed ID: 202421
    [Abstract] [Full Text] [Related]

  • 6. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR, Yeshurun D, Jackson RL, Gotto AM.
    Am J Med; 1977 Dec 01; 63(6):1001-9. PubMed ID: 204188
    [No Abstract] [Full Text] [Related]

  • 7. [Hyperlipoproteinemia].
    Meinders AE.
    Ned Tijdschr Geneeskd; 1979 Mar 14; 123(15):617-28. PubMed ID: 219378
    [No Abstract] [Full Text] [Related]

  • 8. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG, Haft GK, Juliano J.
    Atherosclerosis; 1976 Mar 14; 23(3):413-27. PubMed ID: 178325
    [Abstract] [Full Text] [Related]

  • 9. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB.
    Am J Med; 1979 Feb 14; 66(2):303-10. PubMed ID: 218451
    [No Abstract] [Full Text] [Related]

  • 10. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
    Olsson AG, Lang PD.
    Atherosclerosis; 1978 Dec 14; 31(4):421-8. PubMed ID: 215174
    [Abstract] [Full Text] [Related]

  • 11. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
    Olsson AG, Lang PD.
    Atherosclerosis; 1978 Dec 14; 31(4):429-33. PubMed ID: 215175
    [Abstract] [Full Text] [Related]

  • 12. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA, Grundy SM.
    JAMA; 1984 May 04; 251(17):2241-6. PubMed ID: 6368883
    [Abstract] [Full Text] [Related]

  • 13. The effect of cholestyramine on lipoprotein lipids in patients with primary type IIA hyperlipoproteinemia.
    Weisweiler P, Neureuther G, Schwandt P.
    Atherosclerosis; 1979 Jul 04; 33(3):295-300. PubMed ID: 226105
    [Abstract] [Full Text] [Related]

  • 14. Type IV hyperlipoproteinaemia.
    Kwiterovich PO, Margolis S.
    Clin Endocrinol Metab; 1973 Mar 04; 2(1):41-71. PubMed ID: 4359117
    [No Abstract] [Full Text] [Related]

  • 15. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P, Weisweiler P, Neureuther G.
    Artery; 1979 Feb 04; 5(2):117-24. PubMed ID: 231950
    [Abstract] [Full Text] [Related]

  • 16. Effect of Al-chlorophenoxyisobutyrate (Alufibrate) on pyruvate metabolism and on the fate of very low density lipoprotein lipids in hyperlipidemic patients.
    Stähelin HB, Locher JT, Maier R.
    Clin Chim Acta; 1974 Jul 15; 54(1):115-22. PubMed ID: 4367872
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Jul 15; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG, Lavy A, Aviram M, Zinder O.
    Atherosclerosis; 1980 Aug 15; 36(4):461-9. PubMed ID: 7417365
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.